Annual report pursuant to Section 13 and 15(d)


5 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 31, 2020
Cash Flows from Operating Activities:    
Net income (loss) $ (378,919) $ (1,531,192)
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Formation costs paid by Sponsor 5,000  
Interest earned on marketable securities held in Trust Account (414,479) (744,021)
Change in fair value of warrant liabilities 616,500 1,479,600
Transaction costs allocable to warrant liabilities 4,078  
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (129,666) 64,365
Accounts payable and accrued expenses 65,716 144,016
Net cash used in operating activities (231,770) (587,232)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account (138,000,000)  
Net cash used in investing activities (138,000,000)  
Cash Flows from Financing Activities    
Proceeds from sale of Units, net of underwriting discounts paid 135,240,000  
Proceeds from sale of Private Warrants 4,110,000  
Proceeds from convertible promissory note - related party   500,000
Repayment of promissory note - related party (93,798)  
Payment of offering costs (312,370)  
Net cash provided by financing activities 138,943,832 500,000
Net Change in Cash 712,062 (87,232)
Cash - Beginning   712,062
Cash - Ending 712,062 624,830
Supplemental Disclosure of Non-Cash Investing and Financing activities:    
Initial classification of ordinary shares subject to possible redemption 132,539,620  
Change in value of ordinary share subject to possible redemption (321,930) $ (1,531,200)
Initial classification of warrant liabilities 1,356,300  
Issuance of Representative Shares 1,137  
Payment of offering costs through promissory note - related party 88,798  
Offering costs paid directly by shareholder in exchange for issuance of ordinary shares $ 25,000